ABBV ▲ +1.5% - AbbVie Inc.
$ABBV - New SKYRIZI® (risankizumab-rzaa) and RINVOQ® (upadacitinib) Data Demonstrate Disease Control for Patients Living With Inflammatory Bowel Disease
11-OCT-2026 01:01 PM ET
Share this post
More filings for $ABBV
ABBV ▲ +0.6% - AbbVie Inc.Oct 7, 2026ABBV ▲ +0.6% - AbbVie Inc.Oct 5, 2026ABBV ▼ -0.1% - AbbVie Inc.Oct 1, 2026ABBV ▼ -0.0% - AbbVie Inc.Oct 1, 2026ABBV ▼ -1.2% - AbbVie Inc.Sep 30, 2026ABBV ▼ -1.2% - AbbVie Inc.Sep 30, 2026
View full $ABBV filing history →💬 Comments
Loading comments…
Leave a comment